Toyota is working on the next phase of its vehicle-to-grid (V2G) pilot in Texas. The company is studying the ways that its EVs can support the electric grid better, especially during emergencies.
This is read by an automated voice. Please report any issues or inconsistencies here. Amazon-owned Zoox is offering free robotaxi rides to members of the public in San Francisco for the first time.
An enraged University of Iowa student was arrested after a Turning Point USA table was flipped on campus in an incident that was caught on video. Just as the video began, a man identified as Justin ...
Cincinnati is addressing a police officer shortage with a new understudy program for young adults. The department is currently about 15% short on sworn officers, reflecting a nationwide trend. An ...
In an unprecedented situation, millions of Americans could lose access to a crucial food assistance program in the coming weeks amid the federal government shutdown. The US Department of Agriculture ...
A day program has opened in Springfield, which serves adults with developmental disabilities. The program is geared towards supporting the interests of people who go there, rather than focusing on ...
The Texas comptroller’s office has picked New York-based tech company Odyssey to manage the state’s $1 billion private school voucher program, putting the four-year-old company in charge of selecting ...
Readers on TikTok and Instagram are making the aesthetics of reading more visible than ever with creative, and often intricate, annotations. Called marginalia, these markups can be elaborate, with ...
Forbes contributors publish independent expert analyses and insights. I’m a clear communications expert and Plain Language advocate. I work with people all the time who sound completely different when ...
Four years ago, at a beach in Antigua, under an umbrella and with a drink in hand, Alex Golesh created the blueprint for his first head coaching job. Beside him, nestled in her reclining chair, wife ...
A breakthrough mRNA cancer vaccine has shown the ability to supercharge the effects of immunotherapy in mice, sparking hope for a universal “off-the-shelf” treatment that could fight multiple cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results